Our Service Catalogue is divided into two distinct parts to clearly demarcate tests covered under NABL accreditation and those that are not. Tests are grouped based on their NABL accreditation status.
1p/19q co–deletion by FISH
Specimen
FFPE block
Type of test
Diagnostic
Organ
Brain
Department/ Section
Cytogenetics
ALK by IHC
Specimen
FFPE block
Type of test
Biomarker
Organ
Lung
Department/ Section
Histopathology
ALK/ROS1/PDL1 (IHC)
Specimen
FFPE block
Type of test
Biomarker & Companion diagnostic
Organ
Lung
Department/ Section
Histopathology
Androgen Receptor (AR) by IHC
Specimen
FFPE block
Type of test
Biomarker
Organ
Department/ Section
Histopathology
ATF1–CREB–1 translocation by RT PCR
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Molecular Diagnostics
BCL2 translocation/rearrangement by FISH
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Cytogenetics
BCL2, BCL6 & C–MYC translocation/rearrangement analysis by FISH.
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Cytogenetics
BCL6 translocation/rearrangement by FISH
Specimen
FFPE block
Type of test
Diagnostic
Organ
Department/ Section
Cytogenetics
Bone marrow aspiration
Specimen
Type of test
Diagnostic
Organ
Department/ Section
Cytology
Bone Marrow Biopsy
Specimen
Bone marrow in formalin
Type of test
Diagnostic
Organ
Bone Marrow
Department/ Section
Histopathology
52 gene Focused Cancer NGS panel (DNA +RNA) – Mutation, Fusion & Copy Number alterations
Specimen
FFPE blocks with tumour cellularity of more than 20%
Type of test
Prognostic & Predictive
Organ
Department/ Section
Molecular Diagnostics
Colon Carcinoma Panel (Cancer Hotspot Mutation Panel by NGS + MMR by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Colon / Intestine
Department/ Section
Histopathology / Molecular Diagnostics
Endometrial Carcinoma Panel (P53 by IHC + POLE + MMR by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Uterus
Department/ Section
Histopathology / Molecular Diagnostics
HPV DNA high risk extended genotyping detection assay (FDA & CE IVD approved) – LBC Collection vial
Specimen
Cervical brush scrapped material in Surepath LBC vial
Type of test
Diagnostic, Screening
Organ
Cervix
Department/ Section
Molecular Diagnostics
HPV DNA high risk extended genotyping detection assay (FDA & CE IVD approved) – Self collection kit
Specimen
Sample collected in FLOQ Vaginal swabs
Type of test
Diagnostic, Screening
Organ
Cervix
Department/ Section
Molecular Diagnostics
IDH 1 & 2 (Isocitrate Dehydrogenase 1 & 2) gene mutation detection assay
Specimen
FFPE block with tumour cellularity of more than 10% or Blood sample or Bone marrow aspirate sample in EDTA vial (3–5 ml)
Type of test
Diagnostic
Organ
Brain
Department/ Section
Molecular Diagnostics
Lung Carcinoma Panel (Lung Biopsy Review + 52 gene Focus NGS Panel + PDL–1 by IHC)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Diagnostic, Predictive, Prognostic
Organ
Lung
Department/ Section
Histopathology / Molecular Diagnostics
MGMT (O6– Methyl Guanine Methyl Transferase) gene promoter methylation detection assay
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Prognostic, Predictive
Organ
Brain
Department/ Section
Molecular Diagnostics
PIK3CA mutation detection assay (Exon 7, 9, 20)
Specimen
FFPE block with tumour cellularity of more than 10%
Type of test
Prognostic & Predictive
Organ
Department/ Section
Molecular Diagnostics
POLE gene mutation analysis (Exon 9,10,11,12,13,14)
Specimen
FFPE block with tumour cellularity of more than 20%
Type of test
Organ
Uterus
Department/ Section
Molecular Diagnostics